At a glance
ClinicalIndex Comparison RecordN/ACompleted· 180 enrolled
Drug / intervention
Peanuts +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Arginine Rich Food Supplementation as an Adjuvant Treatment Against Tuberculosis
In Brief
A clinical study evaluating Peanuts and Daboqolo for Tuberculosis and HIV. Completed, enrolled 180 participants across 1 site.
Detailed Summary
The purpose of this study was to investigate if adjuvant treatment with arginine (the substrate for nitric oxide production) rich food supplements could improve clinical outcome in patients with smear positive tuberculosis by affecting nitric oxide production.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTuberculosis, HIV
CountriesEthiopia
CollaboratorsUniversity of Gondar, Kalmar County Hospital
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2004
Primary CompletionDec 2006
First PostedMar 2009
TodayJul 2026
First PostedMar 6, 2009
Enrollment StartFeb 1, 2004
Primary CompletionDec 1, 2006
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 17.3 years ago
Interventions
Peanutsdietary
30g of peanuts daily for 4 weeks (directly observed). This dose of peanuts is equivalent to 1 gram of arginine.
Daboqolodietary
30g of Daboqolo per os daily for 4 weeks (given supervised). 30g of Daboqolo is equivalent to 0.1 g of arginine.